drugset / Trial / NCT01752959

A Comparison of Esmolol and Remifentanil to Reduce Blood Loss

NCT01752959

Phase 4 Unknown 60 enrolled Diskapi Teaching and Research Hospital
RandomizedParallel-groupOpen-label

Summary

In this prospective randomized study we aimed to compare the effects of esmolol and remifentanil on intraoperative bleeding surgical field conditions in nasal surgery

Timeline

Start
2012-07
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified 50 ug/kg Intravenous
Subject Esmolol Other / unclassified 500 ug/kg Intravenous
Comparator Remifentanil Small molecule 0.1 ug/kg Intravenous
Comparator Remifentanil Small molecule 0.3 ug/kg Intravenous